These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34884767)

  • 1. A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.
    Ghafouri-Fard S; Azimi T; Hussen BM; Taheri M; Jalili Khoshnoud R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis.
    Wang X; Zhang H; Lu X; Li S; Kong X; Liu L; Li L; Xu S; Wang T; Wang J; Wang L
    PeerJ; 2022; 10():e13454. PubMed ID: 35602889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses.
    Li S; Wang X; Wang T; Zhang H; Lu X; Liu L; Li L; Bo C; Kong X; Xu S; Ning S; Wang J; Wang L
    J Transl Med; 2021 Nov; 19(1):468. PubMed ID: 34794447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs.
    Fiorillo AA; Heier CR; Huang YF; Tully CB; Punga T; Punga AR
    Front Immunol; 2020; 11():151. PubMed ID: 32153563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine.
    Iacomino N; Tarasco MC; Berni A; Ronchi J; Mantegazza R; Cavalcante P; Foti M
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.
    Li J; Qiu D; Chen Z; Du W; Liu J; Mo X
    Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as potential biomarkers in myasthenia gravis patients.
    Punga AR; Punga T
    Ann N Y Acad Sci; 2018 Jan; 1412(1):33-40. PubMed ID: 29125182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
    Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
    Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The key roles of non-coding RNAs in the pathophysiology of hypertension.
    Ghafouri-Fard S; Shirvani-Farsani Z; Hussen BM; Taheri M; Samsami M
    Eur J Pharmacol; 2022 Sep; 931():175220. PubMed ID: 35995213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA growth arrest specific 5 regulates the T helper 17/regulatory T balance by targeting miR-23a in myasthenia gravis.
    Xu Y; Ouyang Y
    J Int Med Res; 2022 Jun; 50(6):3000605211053703. PubMed ID: 35707849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p.
    Beretta F; Huang YF; Punga AR
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs and type 2 diabetes mellitus.
    Taheri M; Eghtedarian R; Ghafouri-Fard S; Omrani MD
    Arch Physiol Biochem; 2023 Apr; 129(2):526-535. PubMed ID: 33155514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine.
    Sabre L; Punga T; Punga AR
    Front Immunol; 2020; 11():213. PubMed ID: 32194544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases.
    Tamgue O; Mezajou CF; Ngongang NN; Kameni C; Ngum JA; Simo USF; Tatang FJ; Akami M; Ngono AN
    Front Immunol; 2021; 12():703936. PubMed ID: 34737736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis.
    Cao Y; Wang J; Zhang H; Tian Q; Chen L; Ning S; Liu P; Sun X; Lu X; Song C; Zhang S; Xiao B; Wang L
    Biomed Res Int; 2015; 2015():724715. PubMed ID: 25705681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: A systematic review.
    Saghazadeh A; Rezaei N
    Int Immunopharmacol; 2022 Nov; 112():109205. PubMed ID: 36087508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFNA-AS1 regulates CD4
    Luo M; Liu X; Meng H; Xu L; Li Y; Li Z; Liu C; Luo YB; Hu B; Xue Y; Liu Y; Luo Z; Yang H
    Clin Immunol; 2017 Oct; 183():121-131. PubMed ID: 28822831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Regulatory Role of lncRNA SNHG16 in Myasthenia Gravis by Constructing a Competing Endogenous RNA Network.
    Wang J; Cao Y; Lu X; Wang X; Kong X; Bo C; Li S; Bai M; Jiao Y; Gao H; Yao X; Ning S; Wang L; Zhang H
    Mol Ther Nucleic Acids; 2020 Mar; 19():1123-1133. PubMed ID: 32059338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.